Ginseng increases intestinal elimination of albendazole sulfoxide in the rat

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 136, Issue 1, 2003, Pages 9-15

  Merino, Gracia ^a   Molina, Antonio J ^a   García, José L ^a   Pulido, Mivis M ^a   Prieto, Julio G ^a   Álvarez, Ana I ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Albendazole; Albendazole sulfoxide; Benzimidazoles; Drug interactions; Ginseng; Herbal products; Intestinal elimination; Rat

Indexed keywords

ALBENDAZOLE SULFOXIDE; BENZIMIDAZOLE DERIVATIVE; GINSENG EXTRACT;

ARTICLE; CONTROLLED STUDY; DIET; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE;

PANAX GINSENG;

EID: 1242348544     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1532-0456(03)00145-5     Document Type: Article

References (29)

1. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58:1999;1685-1693.
2. Bahrke M.S., Morgan W.P. Evaluation of the ergogenic properties of ginseng. Sports Med. 29:2000;113-133.
3. Bennett A., Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol. Today. 16:2000;71-74.
4. Cabral de Oliveira A.C., Perez A.C., Merino G., Prieto J.G., Alvarez A.I. Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise. Comp. Biochem. Physiol., Part C. 130:2001;369-377.
5. Costa S.F., Weiss L.M. Drug treatment of microsporidiosis. Drug Resist. Updates. 3:2000;384-399.
6. El-On J. Benzimidazole treatment of cystic echinococcosis. Acta Trop. 85:2002;243-252.
7. Fattinger K., Meier-Abt A. Interactions of phytotherapeutic drugs, foods and drinks with medicines. Ther. Umsch. 59:2002;292-300.
8. +-ATPase. Comp. Biochem. Physiol., Part C. 128:2001;531-540.
9. Goso Y., Ogata Y., Ishihara K., Hotta K. Effects of traditional herbal medicine on gastric mucin against ethanol-induced gastric injury in rats. Comp. Biochem. Physiol., Part C. 113:1996;17-21.
10. Hasegawa H., Sung J.H., Matsumiya S., et al. Reversal of daunomycin and vinblastine resistance in multidrug-resistance P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med. 61:1995;409-413.
11. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica. 32:2002;451-478.
12. 3. Biochem. Pharmacol. 65:2003;75-82.
13. Lopez-García M.L., Torrado-Duran S., Torrado-Duran J., Martnez-Fernandez A.R., Bolas-Fernandez F. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and paranteral stages of Trichinella spiralis in mice. Int. J. Parasitol. 27:1997;781-785.
14. Mahady G.B., Gyllenhaal C., Fong H.H.S., Farnswort N.R. Ginsengs: a review of safety and efficacy. Nutr. Clin. 3:2000;90-101.
15. Merino G., Alvarez A.I., Prieto J.G., Kim R.B. The anthelminthic agent albendazole does not interact with P-glycoprotein. Drug Metab. Dispos. 30:2002;365-369.
16. Park, K.S., Kim, H.J., Lee, D.E., Sung, J.H., Chung, S.H., 2002. Hypoglycemic activity of Panax ginseng in animal and human studies. In: Baek, N.I. (Ed.), The Eighth International Symposium on Ginseng, Seoul, Korea. Advances in Ginseng Research 2002, pp. 117-128.
17. Pourgholami M.H., Woon L., Almajd R., Akhter J., Bowery P., Morris D.L. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 165:2001;43-49.
18. Prieto J.G., Merino G., Pulido M.M., et al. Improved L.C. method to determine ivermectin in plasma. J. Pharm. Biomed. Anal. 31:2003;639-645.
19. Rabbaa L., Dautrey S., Colas-Linhart N., Carbon C., Farinotti R. Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process. Antimicrob. Agents Chemother. 36:1996;2506-2511.
20. Rawden H.L., Kokwaro G.O., Ward S.A., Edwards G. Relative contribution of cytochromes P450 and flavin-containing monooxygenases to the metabolism of albendazole by human liver microsomes. Br. J. Clin. Pharmacol. 49:2000;313-322.
21. Redondo P.A., Alvarez A.I., García J.L., Villaverde C., Prieto J.G. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats. Biopharm. Drug Dispos. 19:1998;65-70.
22. Redondo P.A., Alvarez A.I., García J.L., Larrodé O.M., Merino G., Prieto J.G. Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen. Drug Metab. Dispos. 27:1999;736-740.
23. Scott G.N., Elmer G.W. Update on natural product-drug interactions. Am. J. Health-Syst. Pharm. 59:2002;339-347.
24. Shin H.R., Kim J.Y., Yun T.K., Morgan G., Vainio H. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control. 11:2000;565-576.
25. Villaverde C., Alvarez A.I., Redondo P., Voces J., Del Estal J.L., Prieto J.G. Small intestinal sulphoxidation of albendazole. Xenobiotica. 25:1995;433-441.
26. Voces J., Alvarez A.I., Vila L., Ferrando A., Cabral de Oliveira C., Prieto J.G. Effects of administration of the standardized Panax ginseng extract G115 on hepatic antioxidant function after exhaustive exercise. Comp. Biochem. Physiol., Part C. 123:1999;175-184.
27. Vuksan V., Sievenpiper J.L., Koo V.Y.Y., et al. American ginseng (Panax quinquefolius L.) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 Diabetes mellitus. Arch. Int. Med. 160:2000;1009-1013.
28. Zhu B.T. A novel hypothesis for the mechanism of action of P-glycoprotein as a multidrug transporter. Mol. Carcinog. 25:1999;1-13.
29. Zulu I., Veitch A., Sianongo S., et al. Albendazole chemotherapy for AIDS-related diarrhoea in Zambia-clinical, parasitological and mucosal responses. Alim. Pharmacol. Ther. 16:2002;595-601.